Turn Therapeutics Inc. Common Stock

TTRXNASDAQ • USD
8.37 USD
↘ 0.19 (2.16%)🟢LIVE (AS OF 02:26 PM EST)
🟢Market: OPEN

Turn Therapeutics Inc. Common Stock (TTRX) trades at $8.37 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$8.75
High?$9.03
Low?$8.10
Prev. Close?$8.55
Volume?90.5K
Avg. Volume?97.8K
VWAP?$8.30
Rel. Volume?0.93x
Bid / Ask
Bid?$6.94 × 100
Ask?$9.59 × 100
Spread?$2.65
Midpoint?$8.27
Valuation & Ratios
Market Cap?261.4M
Shares Out?N/A
Float?14.4M
Float %?47.2%
P/E Ratio?N/A
P/B Ratio?45.92
EPS?-$0.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Employees
2
Market Cap
261.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-10-08
Address
250 NORTH WESTLAKE BLVD.
WESTLAKE VILLAGE, CA 91362
Phone: (818) 564-4011
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
59
Piotroski F-Score?0/9Weak
Altman Z-Score?10.82Safe
Confidence?28%Very Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?3.68%Low
Short Interest?530.5K
Days to Cover?5.9
Free Float14.4M
Avg Daily Volume90.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.19Strong
Quick Ratio?3.19Strong
Cash Ratio?2.98Strong
Debt/Equity?1.09Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
45.92HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-36.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-224.4%WEAK▾
ROA?
S&P
3
-78.1%WEAK▾
Cash Flow & Enterprise
FCF?$-5281841
Enterprise Value?$257.2M
Fundamentals ratios updated end of day